Please select the option that best describes you:

Is there a clinically significant increased risk of venous thromboembolism with the use of fulvestrant for metastatic HR+ breast cancer?   

In a patient with a history of VTE (now off anticoagulants), is it safe to administer fulvestrant?



Answer from: Medical Oncologist at Academic Institution
Sign in or Register to read more